Sarita Kapila
Stock Analyst at Morgan Stanley
(0.58)
# 4,250
Out of 4,698 analysts
60
Total ratings
37.1%
Success rate
-6.4%
Average return
Main Sectors:
Stocks Rated by Sarita Kapila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Maintained: Sell | 1,700p → 1,900p | 1,867p | +1.79% | 9 | Aug 25, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €100.00 → €82.00 | €76.27 | +7.51% | 2 | Aug 11, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Buy | $46 → $63 | $55.32 | +13.88% | 3 | Aug 7, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,500p → 15,300p | 12,146p | +25.97% | 12 | Jul 16, 2026 | |
| SNY Sanofi | Maintained: Hold | $52 → $49 | $44.34 | +10.52% | 4 | Jul 8, 2026 | |
| SWX: ROP Roche Holding AG | Upgraded: Hold | CHF 295.00 | CHF 356.50 | -17.25% | 10 | Apr 24, 2026 | |
| LON: 0NZT UCB SA | Downgraded: Hold | €260.00 | €220.15 | +18.10% | 6 | Mar 6, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Hold | kr 253.10 → kr 257.88 | kr 460.00 | n/a | 2 | May 4, 2023 | |
| GRFS Grifols | Maintained: Buy | $16 → $19 | $7.88 | n/a | 2 | Feb 8, 2023 | |
| BME: GRF Grifols, S.A. | Maintained: Buy | €14.00 → €16.00 | €9.93 | n/a | 6 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $36 | $47.64 | n/a | 4 | Nov 16, 2022 |
GSK plc
Aug 25, 2026
Maintained: Sell
Price Target: 1,700p → 1,900p
Current: 1,867p
Upside: +1.79%
Sanofi
Aug 11, 2026
Maintained: Hold
Price Target: €100.00 → €82.00
Current: €76.27
Upside: +7.51%
Roche Holding AG
Aug 7, 2026
Upgraded: Buy
Price Target: $46 → $63
Current: $55.32
Upside: +13.88%
AstraZeneca PLC
Jul 16, 2026
Maintained: Buy
Price Target: 16,500p → 15,300p
Current: 12,146p
Upside: +25.97%
Sanofi
Jul 8, 2026
Maintained: Hold
Price Target: $52 → $49
Current: $44.34
Upside: +10.52%
Roche Holding AG
Apr 24, 2026
Upgraded: Hold
Price Target: CHF 295.00
Current: CHF 356.50
Upside: -17.25%
UCB SA
Mar 6, 2026
Downgraded: Hold
Price Target: €260.00
Current: €220.15
Upside: +18.10%
Swedish Orphan Biovitrum AB (publ)
May 4, 2023
Maintained: Hold
Price Target: kr 253.10 → kr 257.88
Current: kr 460.00
Upside: n/a
Grifols
Feb 8, 2023
Maintained: Buy
Price Target: $16 → $19
Current: $7.88
Upside: n/a
Grifols, S.A.
Feb 8, 2023
Maintained: Buy
Price Target: €14.00 → €16.00
Current: €9.93
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $36
Current: $47.64
Upside: n/a